WHO launches first trial of antiviral to prevent Bundibugyo strain of Ebola

AI Summary

The World Health Organization began the first clinical trial testing an antiviral to prevent the Bundibugyo Ebola strain in the Democratic Republic of Congo amid a continuing outbreak.

The World Health Organization launched the first clinical trial on Tuesday to test whether an antiviral drug can prevent infection in people exposed to the Bundibugyo strain of Ebola in the Democratic Republic of Congo, as the outbreak continues to outpace response efforts and spread beyond known chains of transmission.